Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.

<h4>Background</h4>Tegumentary leishmaniasis (TL) is a parasitic disease that can present a cutaneous or mucocutaneous clinical form (CL and MCL, respectively). The disease is caused by different Leishmania species and transmitted by phlebotomine sand flies. Bolivia has one of the highes...

Full description

Bibliographic Details
Main Authors: Cristina Ballart, Mary Cruz Torrico, Gisela Vidal, Faustino Torrico, Daniel Lozano, Montserrat Gállego, Lilian Pinto, Ernesto Rojas, Ruth Aguilar, Carlota Dobaño, Sonia Ares-Gomez, Albert Picado
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0009223
id doaj-7a1425a9a5d74088b9c65a0b2e07fb8f
record_format Article
spelling doaj-7a1425a9a5d74088b9c65a0b2e07fb8f2021-06-30T04:30:43ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352021-03-01153e000922310.1371/journal.pntd.0009223Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.Cristina BallartMary Cruz TorricoGisela VidalFaustino TorricoDaniel LozanoMontserrat GállegoLilian PintoErnesto RojasRuth AguilarCarlota DobañoSonia Ares-GomezAlbert Picado<h4>Background</h4>Tegumentary leishmaniasis (TL) is a parasitic disease that can present a cutaneous or mucocutaneous clinical form (CL and MCL, respectively). The disease is caused by different Leishmania species and transmitted by phlebotomine sand flies. Bolivia has one of the highest incidences of the disease in South America and the diagnosis is done by parasitological techniques. Our aim was to describe the clinical and immunological characteristics of CL and MCL patients attending the leishmaniasis reference center in Cochabamba, Bolivia, in order to gain updated clinical and epidemiological information, to evaluate the diagnostic methods used and to identify biomarkers related to clinical disease and its evolution.<h4>Methodology/principal findings</h4>The study was conducted from September 2014 to November 2015 and 135 patients with lesions compatible with CL or MCL were included. Epidemiological and clinical data were collected using a semi-structured questionnaire. Two parasitological diagnostic methods were used: Giemsa-stained smears and culture of lesion aspirates. Blood samples obtained from participants were used to measure the concentrations of different cytokines. 59.2% (80/135) were leishmaniasis confirmed cases (CL: 71.3%; MCL: 28.7%). Sixty percent of the confirmed cases were positive by smears and 90.6% were positive by culture. 53.8% were primo-infections. Eotaxin and monokine induced by IFN-γ presented higher serum concentrations in the MCL clinical presentation compared to CL cases and no-cases. None of the cytokines presented different concentrations between primo-infections and secondary infections due to treatment failure.<h4>Conclusions/significance</h4>In Bolivia, parasitological diagnosis remains the reference standard in diagnosis of leishmaniasis because of its high specificity, whereas the sensitivity varies over a wide range leading to loss of cases. Until more accurate tools are implemented, all patients should be tested by both smears and culture of lesion aspirates to minimize the risk of false negatives. Our results showed higher concentrations of several cytokines in MCL compared to CL, but no differences were observed between CL and no-cases. In addition, none of the cytokines differed between primary and secondary infections. These results highlight the need of further research to identify biomarkers of susceptibility and disease progression, in addition to looking at the local cellular immune responses in the lesions.https://doi.org/10.1371/journal.pntd.0009223
collection DOAJ
language English
format Article
sources DOAJ
author Cristina Ballart
Mary Cruz Torrico
Gisela Vidal
Faustino Torrico
Daniel Lozano
Montserrat Gállego
Lilian Pinto
Ernesto Rojas
Ruth Aguilar
Carlota Dobaño
Sonia Ares-Gomez
Albert Picado
spellingShingle Cristina Ballart
Mary Cruz Torrico
Gisela Vidal
Faustino Torrico
Daniel Lozano
Montserrat Gállego
Lilian Pinto
Ernesto Rojas
Ruth Aguilar
Carlota Dobaño
Sonia Ares-Gomez
Albert Picado
Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
PLoS Neglected Tropical Diseases
author_facet Cristina Ballart
Mary Cruz Torrico
Gisela Vidal
Faustino Torrico
Daniel Lozano
Montserrat Gállego
Lilian Pinto
Ernesto Rojas
Ruth Aguilar
Carlota Dobaño
Sonia Ares-Gomez
Albert Picado
author_sort Cristina Ballart
title Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
title_short Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
title_full Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
title_fullStr Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
title_full_unstemmed Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
title_sort clinical and immunological characteristics of tegumentary leishmaniasis cases in bolivia.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2021-03-01
description <h4>Background</h4>Tegumentary leishmaniasis (TL) is a parasitic disease that can present a cutaneous or mucocutaneous clinical form (CL and MCL, respectively). The disease is caused by different Leishmania species and transmitted by phlebotomine sand flies. Bolivia has one of the highest incidences of the disease in South America and the diagnosis is done by parasitological techniques. Our aim was to describe the clinical and immunological characteristics of CL and MCL patients attending the leishmaniasis reference center in Cochabamba, Bolivia, in order to gain updated clinical and epidemiological information, to evaluate the diagnostic methods used and to identify biomarkers related to clinical disease and its evolution.<h4>Methodology/principal findings</h4>The study was conducted from September 2014 to November 2015 and 135 patients with lesions compatible with CL or MCL were included. Epidemiological and clinical data were collected using a semi-structured questionnaire. Two parasitological diagnostic methods were used: Giemsa-stained smears and culture of lesion aspirates. Blood samples obtained from participants were used to measure the concentrations of different cytokines. 59.2% (80/135) were leishmaniasis confirmed cases (CL: 71.3%; MCL: 28.7%). Sixty percent of the confirmed cases were positive by smears and 90.6% were positive by culture. 53.8% were primo-infections. Eotaxin and monokine induced by IFN-γ presented higher serum concentrations in the MCL clinical presentation compared to CL cases and no-cases. None of the cytokines presented different concentrations between primo-infections and secondary infections due to treatment failure.<h4>Conclusions/significance</h4>In Bolivia, parasitological diagnosis remains the reference standard in diagnosis of leishmaniasis because of its high specificity, whereas the sensitivity varies over a wide range leading to loss of cases. Until more accurate tools are implemented, all patients should be tested by both smears and culture of lesion aspirates to minimize the risk of false negatives. Our results showed higher concentrations of several cytokines in MCL compared to CL, but no differences were observed between CL and no-cases. In addition, none of the cytokines differed between primary and secondary infections. These results highlight the need of further research to identify biomarkers of susceptibility and disease progression, in addition to looking at the local cellular immune responses in the lesions.
url https://doi.org/10.1371/journal.pntd.0009223
work_keys_str_mv AT cristinaballart clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT marycruztorrico clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT giselavidal clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT faustinotorrico clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT daniellozano clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT montserratgallego clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT lilianpinto clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT ernestorojas clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT ruthaguilar clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT carlotadobano clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT soniaaresgomez clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
AT albertpicado clinicalandimmunologicalcharacteristicsoftegumentaryleishmaniasiscasesinbolivia
_version_ 1721353626699431936